FDA.reportPublic FDA data

TEMBEXA 10 MG/mL Oral Suspension

RxCUI
2599531
RxNorm name
TEMBEXA 10 MG/mL Oral Suspension
Display name
TEMBEXA 10 MG/mL Oral Suspension
Full name
TEMBEXA 10 MG/mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TembexaBRINCIDOFOVIREmergent BioDefense Operations Lansing LLC0784838e-00bd-4b14-9b7e-653b7fbb7eea2025-07-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2599531

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
12569e7c-9c2a-4b8b-94e2-f05607b4a866TEMBEXA 10 MG/mL Oral Suspension [PSN] · brincidofovir 10 MG/ML Oral Suspension [Tembexa] [SBD] · Tembexa 10 MG/ML Oral Suspension [SY]34These highlights do not include all the information needed to use TEMBEXA ® safely and effectively. See full prescribing information for TEMBEXA. TEMBEXA (brincidofovir) tablets, for oral use TEMBEXA (brincidofovir) oral suspension Initial U.S. Approval: 199620220418
0784838e-00bd-4b14-9b7e-653b7fbb7eeaTEMBEXA 10 MG/mL Oral Suspension [PSN] · brincidofovir 10 MG/ML Oral Suspension [Tembexa] [SBD] · Tembexa 10 MG/ML Oral Suspension [SY]32These highlights do not include all the information needed to use TEMBEXA ® safely and effectively. See full prescribing information for TEMBEXA. TEMBEXA (brincidofovir) tablets, for oral use TEMBEXA (brincidofovir) oral suspension Initial U.S. Approval: 199620250723